Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

Anna Felberg, Aleksandra Urban, Anna Borowska, Grzegorz Stasiłojć, Michał Taszner, Andrzej Hellmann, Anna Maria Blom, Marcin Okrój

ABSTRACT

Anti-CD20 monoclonal antibodies (mAbs) rituximab and ofatumumab are potent activators of the classical complement pathway, and have been approved for the treatment of B-cell malignancies. However, complement exhaustion and overexpression of complement inhibitors by cancer cells diminish their therapeutic potential. The strategies of targeting membrane complement inhibitors by function-blocking antibodies and the supplementation with fresh frozen plasma have been proposed to overcome tumour cell resistance. We present a novel approach, which utilizes gain-of-function variants of complement factor B (FB), a component of alternative C3/C5 convertases, which augment mAb-activated reactions through a positive feedback mechanism called an amplification loop. If complement concentration is limited, an addition of quadruple gain-of-function FB mutant p.D279G p.F286L p.K323E p.Y363A (or selected single mutants) results in significantly increased complement-mediated lysis of ofatumumab-resistant tumour cells, as well as the complete lysis of moderately sensitive cells. Importantly, this effect cannot be achieved by further increasing ofatumumab concentration. Potentiation of cytotoxic effect towards moderately sensitive cells was less apparent at physiological serum concentration. However, an addition of hyperactive FB could compensate the loss of cytotoxic potential of serum collected from the NHL and CLL patients after infusion of rituximab. Residual levels of rituximab in such sera, in combination with added FB, were able to efficiently lyse tumour cells. We suggest that the administration of gain-of-function variants of FB can restore cytotoxic potential of complement-exhausted serum and maximize the therapeutic effect of circulating anti-CD20 mAbs. More... »

PAGES

1-12

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00262-019-02304-0

DOI

http://dx.doi.org/10.1007/s00262-019-02304-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111933423

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30725204


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gda\u0144sk and Medical University of Gda\u0144sk, D\u0119binki 1 Street, 80-211, Gda\u0144sk, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Felberg", 
        "givenName": "Anna", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gda\u0144sk and Medical University of Gda\u0144sk, D\u0119binki 1 Street, 80-211, Gda\u0144sk, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Urban", 
        "givenName": "Aleksandra", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gda\u0144sk and Medical University of Gda\u0144sk, D\u0119binki 1 Street, 80-211, Gda\u0144sk, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Borowska", 
        "givenName": "Anna", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gda\u0144sk and Medical University of Gda\u0144sk, D\u0119binki 1 Street, 80-211, Gda\u0144sk, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stasi\u0142oj\u0107", 
        "givenName": "Grzegorz", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gda\u0144sk Medical University", 
          "id": "https://www.grid.ac/institutes/grid.11451.30", 
          "name": [
            "Department of Hematology and Transplantology, Medical University of Gda\u0144sk, Gda\u0144sk, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taszner", 
        "givenName": "Micha\u0142", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gda\u0144sk Medical University", 
          "id": "https://www.grid.ac/institutes/grid.11451.30", 
          "name": [
            "Department of Hematology and Transplantology, Medical University of Gda\u0144sk, Gda\u0144sk, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hellmann", 
        "givenName": "Andrzej", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lund University", 
          "id": "https://www.grid.ac/institutes/grid.4514.4", 
          "name": [
            "Department of Translational Medicine, Lund University, Malm\u00f6, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blom", 
        "givenName": "Anna Maria", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gda\u0144sk and Medical University of Gda\u0144sk, D\u0119binki 1 Street, 80-211, Gda\u0144sk, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okr\u00f3j", 
        "givenName": "Marcin", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1124/mol.114.092684", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000618811"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0603420103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001808724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2013-03-489245", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005035074"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-01-0039", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007647967"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ndt/gfv054", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011567328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/cei.12388", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013260992"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2014.146", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013904824", 
          "https://doi.org/10.1038/leu.2014.146"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neurobiolaging.2011.12.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014879916"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-07-0682", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016959303"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.ki.5000155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017508847", 
          "https://doi.org/10.1038/sj.ki.5000155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.molimm.2009.05.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021007519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa075290", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024267663"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(10)70210-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025422354"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2016.02.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026196880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2014.185", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026908021", 
          "https://doi.org/10.1038/leu.2014.185"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1749-6632.2009.04803.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028326736"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1749-6632.2009.04803.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028326736"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-10-569244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029523279"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1081-1206(10)61257-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030813282"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0047245", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033114168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2012.10.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033504699"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2013.169", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033835773", 
          "https://doi.org/10.1038/leu.2013.169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.leukres.2005.09.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042049383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.leukres.2005.09.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042049383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ki.2012.63", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045948666", 
          "https://doi.org/10.1038/ki.2012.63"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12032-013-0759-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051924360", 
          "https://doi.org/10.1007/s12032-013-0759-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m304620200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052566100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2741/3688", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070915889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/2162402x.2014.979688", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072289042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074262652", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074650646", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.172.5.3280", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1076799270"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.1103693", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078524706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.1302954", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078842671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0179841", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090285472"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/08916934.2017.1423286", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100249845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/10245332.2018.1444563", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101265701"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/10245332.2018.1444563", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101265701"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "Anti-CD20 monoclonal antibodies (mAbs) rituximab and ofatumumab are potent activators of the classical complement pathway, and have been approved for the treatment of B-cell malignancies. However, complement exhaustion and overexpression of complement inhibitors by cancer cells diminish their therapeutic potential. The strategies of targeting membrane complement inhibitors by function-blocking antibodies and the supplementation with fresh frozen plasma have been proposed to overcome tumour cell resistance. We present a novel approach, which utilizes gain-of-function variants of complement factor B (FB), a component of alternative C3/C5 convertases, which augment mAb-activated reactions through a positive feedback mechanism called an amplification loop. If complement concentration is limited, an addition of quadruple gain-of-function FB mutant p.D279G p.F286L p.K323E p.Y363A (or selected single mutants) results in significantly increased complement-mediated lysis of ofatumumab-resistant tumour cells, as well as the complete lysis of moderately sensitive cells. Importantly, this effect cannot be achieved by further increasing ofatumumab concentration. Potentiation of cytotoxic effect towards moderately sensitive cells was less apparent at physiological serum concentration. However, an addition of hyperactive FB could compensate the loss of cytotoxic potential of serum collected from the NHL and CLL patients after infusion of rituximab. Residual levels of rituximab in such sera, in combination with added FB, were able to efficiently lyse tumour cells. We suggest that the administration of gain-of-function variants of FB can restore cytotoxic potential of complement-exhausted serum and maximize the therapeutic effect of circulating anti-CD20 mAbs.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00262-019-02304-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.4716158", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.7396220", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1096240", 
        "issn": [
          "0340-7004", 
          "1432-0851"
        ], 
        "name": "Cancer Immunology, Immunotherapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "68"
      }
    ], 
    "name": "Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics", 
    "pagination": "1-12", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b4fcd7f0cf66d501a0c9adabe7a1c2d874ecb85c005dbd5c8d06fc57b49455df"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30725204"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8605732"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00262-019-02304-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111933423"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00262-019-02304-0", 
      "https://app.dimensions.ai/details/publication/pub.1111933423"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130801_00000006.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00262-019-02304-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00262-019-02304-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00262-019-02304-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00262-019-02304-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00262-019-02304-0'


 

This table displays all metadata directly associated to this object as RDF triples.

236 TRIPLES      21 PREDICATES      64 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00262-019-02304-0 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N444a9778034440de9b71532aebc92b29
4 schema:citation sg:pub.10.1007/s12032-013-0759-5
5 sg:pub.10.1038/ki.2012.63
6 sg:pub.10.1038/leu.2013.169
7 sg:pub.10.1038/leu.2014.146
8 sg:pub.10.1038/leu.2014.185
9 sg:pub.10.1038/sj.ki.5000155
10 https://app.dimensions.ai/details/publication/pub.1074262652
11 https://app.dimensions.ai/details/publication/pub.1074650646
12 https://doi.org/10.1016/j.ctrv.2012.10.008
13 https://doi.org/10.1016/j.ctrv.2016.02.009
14 https://doi.org/10.1016/j.leukres.2005.09.008
15 https://doi.org/10.1016/j.molimm.2009.05.009
16 https://doi.org/10.1016/j.neurobiolaging.2011.12.005
17 https://doi.org/10.1016/s1081-1206(10)61257-4
18 https://doi.org/10.1016/s1470-2045(10)70210-2
19 https://doi.org/10.1056/nejmoa075290
20 https://doi.org/10.1073/pnas.0603420103
21 https://doi.org/10.1074/jbc.m304620200
22 https://doi.org/10.1080/08916934.2017.1423286
23 https://doi.org/10.1080/10245332.2018.1444563
24 https://doi.org/10.1093/ndt/gfv054
25 https://doi.org/10.1111/cei.12388
26 https://doi.org/10.1111/j.1749-6632.2009.04803.x
27 https://doi.org/10.1124/mol.114.092684
28 https://doi.org/10.1158/1078-0432.ccr-07-0682
29 https://doi.org/10.1182/blood-2004-01-0039
30 https://doi.org/10.1182/blood-2013-03-489245
31 https://doi.org/10.1182/blood-2014-10-569244
32 https://doi.org/10.1371/journal.pone.0047245
33 https://doi.org/10.1371/journal.pone.0179841
34 https://doi.org/10.2741/3688
35 https://doi.org/10.4049/jimmunol.1103693
36 https://doi.org/10.4049/jimmunol.1302954
37 https://doi.org/10.4049/jimmunol.172.5.3280
38 https://doi.org/10.4161/2162402x.2014.979688
39 schema:datePublished 2019-04
40 schema:datePublishedReg 2019-04-01
41 schema:description Anti-CD20 monoclonal antibodies (mAbs) rituximab and ofatumumab are potent activators of the classical complement pathway, and have been approved for the treatment of B-cell malignancies. However, complement exhaustion and overexpression of complement inhibitors by cancer cells diminish their therapeutic potential. The strategies of targeting membrane complement inhibitors by function-blocking antibodies and the supplementation with fresh frozen plasma have been proposed to overcome tumour cell resistance. We present a novel approach, which utilizes gain-of-function variants of complement factor B (FB), a component of alternative C3/C5 convertases, which augment mAb-activated reactions through a positive feedback mechanism called an amplification loop. If complement concentration is limited, an addition of quadruple gain-of-function FB mutant p.D279G p.F286L p.K323E p.Y363A (or selected single mutants) results in significantly increased complement-mediated lysis of ofatumumab-resistant tumour cells, as well as the complete lysis of moderately sensitive cells. Importantly, this effect cannot be achieved by further increasing ofatumumab concentration. Potentiation of cytotoxic effect towards moderately sensitive cells was less apparent at physiological serum concentration. However, an addition of hyperactive FB could compensate the loss of cytotoxic potential of serum collected from the NHL and CLL patients after infusion of rituximab. Residual levels of rituximab in such sera, in combination with added FB, were able to efficiently lyse tumour cells. We suggest that the administration of gain-of-function variants of FB can restore cytotoxic potential of complement-exhausted serum and maximize the therapeutic effect of circulating anti-CD20 mAbs.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree false
45 schema:isPartOf N319a284bb004442bac777cce5ad6d5d0
46 Nd20d0add143d4fa598afae36b0f56e42
47 sg:journal.1096240
48 schema:name Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics
49 schema:pagination 1-12
50 schema:productId N22350e8655e04d28ae51327e2f8001ba
51 N6334df0cb62848bc8ba06a26d978310e
52 N8e334768f6864ee3b03c66a6ed7df935
53 Nc81fa77253d741bbaf5b22256c0551dc
54 Ne0e27cd35c754cdfb00cbb885f64db69
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111933423
56 https://doi.org/10.1007/s00262-019-02304-0
57 schema:sdDatePublished 2019-04-11T13:52
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N189a293738eb47b38022364b6a0232c2
60 schema:url https://link.springer.com/10.1007%2Fs00262-019-02304-0
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N016432e3e5c946218851b1a234cd9d45 schema:name Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Dębinki 1 Street, 80-211, Gdańsk, Poland
65 rdf:type schema:Organization
66 N0347f1a9afa74890960fa424bd2622af schema:name Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Dębinki 1 Street, 80-211, Gdańsk, Poland
67 rdf:type schema:Organization
68 N04c4d1efb1444b4ab22276fda6cd0a92 schema:affiliation Nf0ee67a5e35a4fb380745138bacb5361
69 schema:familyName Urban
70 schema:givenName Aleksandra
71 rdf:type schema:Person
72 N16f44a17d0c141c8a6fa42ea93fec15a schema:affiliation N6fc6531702dd4794896e4376aaae2e37
73 schema:familyName Okrój
74 schema:givenName Marcin
75 rdf:type schema:Person
76 N189a293738eb47b38022364b6a0232c2 schema:name Springer Nature - SN SciGraph project
77 rdf:type schema:Organization
78 N22350e8655e04d28ae51327e2f8001ba schema:name doi
79 schema:value 10.1007/s00262-019-02304-0
80 rdf:type schema:PropertyValue
81 N2f8d3fb4323846da9aadcd4c8cac9576 schema:affiliation N0347f1a9afa74890960fa424bd2622af
82 schema:familyName Stasiłojć
83 schema:givenName Grzegorz
84 rdf:type schema:Person
85 N319a284bb004442bac777cce5ad6d5d0 schema:volumeNumber 68
86 rdf:type schema:PublicationVolume
87 N3dbf8f28bead4f21b4fef6b21e6d8daf schema:name Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Dębinki 1 Street, 80-211, Gdańsk, Poland
88 rdf:type schema:Organization
89 N4090c66011ca4405ab5898f97d2a7576 schema:affiliation https://www.grid.ac/institutes/grid.4514.4
90 schema:familyName Blom
91 schema:givenName Anna Maria
92 rdf:type schema:Person
93 N444a9778034440de9b71532aebc92b29 rdf:first Nc9a3c88b073b4fd19cd8fe1dd3beb912
94 rdf:rest N7bfa2d0a904b44af980529f5157dbb34
95 N44cce6c7de624d4e83108b43705f05b4 rdf:first Nb50426c8d924487d96ee52399e38195c
96 rdf:rest N6680777c95994e74b1f6029d61a1d957
97 N5505a985ab2d41459f6d82521e7104ee schema:affiliation https://www.grid.ac/institutes/grid.11451.30
98 schema:familyName Taszner
99 schema:givenName Michał
100 rdf:type schema:Person
101 N6334df0cb62848bc8ba06a26d978310e schema:name dimensions_id
102 schema:value pub.1111933423
103 rdf:type schema:PropertyValue
104 N6680777c95994e74b1f6029d61a1d957 rdf:first N4090c66011ca4405ab5898f97d2a7576
105 rdf:rest N68e7905466924d618f7026747e9a9ea4
106 N68e7905466924d618f7026747e9a9ea4 rdf:first N16f44a17d0c141c8a6fa42ea93fec15a
107 rdf:rest rdf:nil
108 N6924ebbb39cf474eaf0f9a5ad2401938 rdf:first N2f8d3fb4323846da9aadcd4c8cac9576
109 rdf:rest Nf70999303523463d8b72883d59e1dc87
110 N6fc6531702dd4794896e4376aaae2e37 schema:name Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Dębinki 1 Street, 80-211, Gdańsk, Poland
111 rdf:type schema:Organization
112 N7bfa2d0a904b44af980529f5157dbb34 rdf:first N04c4d1efb1444b4ab22276fda6cd0a92
113 rdf:rest N896eef1d63384d4ba7fcb7227ae1c4f7
114 N896eef1d63384d4ba7fcb7227ae1c4f7 rdf:first N92f3f21a00fa4e49a1c65c98efd5b876
115 rdf:rest N6924ebbb39cf474eaf0f9a5ad2401938
116 N8e334768f6864ee3b03c66a6ed7df935 schema:name pubmed_id
117 schema:value 30725204
118 rdf:type schema:PropertyValue
119 N92f3f21a00fa4e49a1c65c98efd5b876 schema:affiliation N016432e3e5c946218851b1a234cd9d45
120 schema:familyName Borowska
121 schema:givenName Anna
122 rdf:type schema:Person
123 Nb50426c8d924487d96ee52399e38195c schema:affiliation https://www.grid.ac/institutes/grid.11451.30
124 schema:familyName Hellmann
125 schema:givenName Andrzej
126 rdf:type schema:Person
127 Nc81fa77253d741bbaf5b22256c0551dc schema:name readcube_id
128 schema:value b4fcd7f0cf66d501a0c9adabe7a1c2d874ecb85c005dbd5c8d06fc57b49455df
129 rdf:type schema:PropertyValue
130 Nc9a3c88b073b4fd19cd8fe1dd3beb912 schema:affiliation N3dbf8f28bead4f21b4fef6b21e6d8daf
131 schema:familyName Felberg
132 schema:givenName Anna
133 rdf:type schema:Person
134 Nd20d0add143d4fa598afae36b0f56e42 schema:issueNumber 4
135 rdf:type schema:PublicationIssue
136 Ne0e27cd35c754cdfb00cbb885f64db69 schema:name nlm_unique_id
137 schema:value 8605732
138 rdf:type schema:PropertyValue
139 Nf0ee67a5e35a4fb380745138bacb5361 schema:name Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Dębinki 1 Street, 80-211, Gdańsk, Poland
140 rdf:type schema:Organization
141 Nf70999303523463d8b72883d59e1dc87 rdf:first N5505a985ab2d41459f6d82521e7104ee
142 rdf:rest N44cce6c7de624d4e83108b43705f05b4
143 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
144 schema:name Medical and Health Sciences
145 rdf:type schema:DefinedTerm
146 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
147 schema:name Oncology and Carcinogenesis
148 rdf:type schema:DefinedTerm
149 sg:grant.4716158 http://pending.schema.org/fundedItem sg:pub.10.1007/s00262-019-02304-0
150 rdf:type schema:MonetaryGrant
151 sg:grant.7396220 http://pending.schema.org/fundedItem sg:pub.10.1007/s00262-019-02304-0
152 rdf:type schema:MonetaryGrant
153 sg:journal.1096240 schema:issn 0340-7004
154 1432-0851
155 schema:name Cancer Immunology, Immunotherapy
156 rdf:type schema:Periodical
157 sg:pub.10.1007/s12032-013-0759-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051924360
158 https://doi.org/10.1007/s12032-013-0759-5
159 rdf:type schema:CreativeWork
160 sg:pub.10.1038/ki.2012.63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045948666
161 https://doi.org/10.1038/ki.2012.63
162 rdf:type schema:CreativeWork
163 sg:pub.10.1038/leu.2013.169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033835773
164 https://doi.org/10.1038/leu.2013.169
165 rdf:type schema:CreativeWork
166 sg:pub.10.1038/leu.2014.146 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013904824
167 https://doi.org/10.1038/leu.2014.146
168 rdf:type schema:CreativeWork
169 sg:pub.10.1038/leu.2014.185 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026908021
170 https://doi.org/10.1038/leu.2014.185
171 rdf:type schema:CreativeWork
172 sg:pub.10.1038/sj.ki.5000155 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017508847
173 https://doi.org/10.1038/sj.ki.5000155
174 rdf:type schema:CreativeWork
175 https://app.dimensions.ai/details/publication/pub.1074262652 schema:CreativeWork
176 https://app.dimensions.ai/details/publication/pub.1074650646 schema:CreativeWork
177 https://doi.org/10.1016/j.ctrv.2012.10.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033504699
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1016/j.ctrv.2016.02.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026196880
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1016/j.leukres.2005.09.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042049383
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1016/j.molimm.2009.05.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021007519
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1016/j.neurobiolaging.2011.12.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014879916
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/s1081-1206(10)61257-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030813282
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/s1470-2045(10)70210-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025422354
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1056/nejmoa075290 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024267663
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1073/pnas.0603420103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001808724
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1074/jbc.m304620200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052566100
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1080/08916934.2017.1423286 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100249845
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1080/10245332.2018.1444563 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101265701
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1093/ndt/gfv054 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011567328
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1111/cei.12388 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013260992
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1111/j.1749-6632.2009.04803.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028326736
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1124/mol.114.092684 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000618811
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1158/1078-0432.ccr-07-0682 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016959303
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1182/blood-2004-01-0039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007647967
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1182/blood-2013-03-489245 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005035074
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1182/blood-2014-10-569244 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029523279
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1371/journal.pone.0047245 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033114168
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1371/journal.pone.0179841 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090285472
220 rdf:type schema:CreativeWork
221 https://doi.org/10.2741/3688 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070915889
222 rdf:type schema:CreativeWork
223 https://doi.org/10.4049/jimmunol.1103693 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078524706
224 rdf:type schema:CreativeWork
225 https://doi.org/10.4049/jimmunol.1302954 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078842671
226 rdf:type schema:CreativeWork
227 https://doi.org/10.4049/jimmunol.172.5.3280 schema:sameAs https://app.dimensions.ai/details/publication/pub.1076799270
228 rdf:type schema:CreativeWork
229 https://doi.org/10.4161/2162402x.2014.979688 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072289042
230 rdf:type schema:CreativeWork
231 https://www.grid.ac/institutes/grid.11451.30 schema:alternateName Gdańsk Medical University
232 schema:name Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland
233 rdf:type schema:Organization
234 https://www.grid.ac/institutes/grid.4514.4 schema:alternateName Lund University
235 schema:name Department of Translational Medicine, Lund University, Malmö, Sweden
236 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...